Sebastian Uhrig

3.0k total citations · 1 hit paper
17 papers, 360 citations indexed

About

Sebastian Uhrig is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Sebastian Uhrig has authored 17 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Sebastian Uhrig's work include Cancer Genomics and Diagnostics (6 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Neuroblastoma Research and Treatments (3 papers). Sebastian Uhrig is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Neuroblastoma Research and Treatments (3 papers). Sebastian Uhrig collaborates with scholars based in Germany, United States and Austria. Sebastian Uhrig's co-authors include Stefan Fröhling, Benedikt Brors, Martina Fröhlich, Barbara Hutter, Albrecht Stenzinger, Umut H. Toprak, Olaf Neumann, Tatjana Walther, Claudia Scholl and Julia Ellermann and has published in prestigious journals such as Science, Bioinformatics and Genome Research.

In The Last Decade

Sebastian Uhrig

17 papers receiving 356 citations

Hit Papers

Accurate and efficient detection of gene fusions from RNA... 2021 2026 2022 2024 2021 50 100 150 200

Peers

Sebastian Uhrig
Alba Mota Spain
Francis Wright United States
Gunes Gundem United States
Rumen Kostadinov United States
Philip Jermann Switzerland
Sara Pepe Italy
Sebastian Uhrig
Citations per year, relative to Sebastian Uhrig Sebastian Uhrig (= 1×) peers Andrzej Sygut

Countries citing papers authored by Sebastian Uhrig

Since Specialization
Citations

This map shows the geographic impact of Sebastian Uhrig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sebastian Uhrig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sebastian Uhrig more than expected).

Fields of papers citing papers by Sebastian Uhrig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sebastian Uhrig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sebastian Uhrig. The network helps show where Sebastian Uhrig may publish in the future.

Co-authorship network of co-authors of Sebastian Uhrig

This figure shows the co-authorship network connecting the top 25 collaborators of Sebastian Uhrig. A scholar is included among the top collaborators of Sebastian Uhrig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sebastian Uhrig. Sebastian Uhrig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hughes, Daniel T., Jordan L. Morris, Fei Gao, et al.. (2024). PERK-ATAD3A interaction provides a subcellular safe haven for protein synthesis during ER stress. Science. 385(6712). eadp7114–eadp7114. 15 indexed citations
2.
Schröter, Julian, Jennifer Hüllein, Vincent Heuveline, et al.. (2023). aRgus: Multilevel visualization of non-synonymous single nucleotide variants & advanced pathogenicity score modeling for genetic vulnerability assessment. Computational and Structural Biotechnology Journal. 21. 1077–1083. 6 indexed citations
3.
Kilian, Michael, Sebastian Uhrig, Alexander Brobeil, et al.. (2022). IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells. Journal for ImmunoTherapy of Cancer. 10(10). e005815–e005815. 5 indexed citations
4.
Uhrig, Sebastian, Philipp J. Jost, Claudio Luchini, et al.. (2022). MCL1 as putative target in pancreatoblastoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 481(2). 265–272. 5 indexed citations
5.
Giesen, Nicola, Nagarajan Paramasivam, Umut H. Toprak, et al.. (2022). Comprehensive genomic analysis of refractory multiple myeloma reveals a complex mutational landscape associated with drug resistance and novel therapeutic vulnerabilities. Haematologica. 107(8). 1891–1901. 12 indexed citations
6.
Simon, Malte, Sadaf S. Mughal, Peter Horak, et al.. (2021). Deconvolution of sarcoma methylomes reveals varying degrees of immune cell infiltrates with association to genomic aberrations. Journal of Translational Medicine. 19(1). 204–204. 3 indexed citations
7.
Hanf, Dorothea, Christoph Heining, Sebastian Uhrig, et al.. (2021). Response to Cabozantinib Following Acquired Entrectinib Resistance in a Patient WithETV6-NTRK3Fusion-Positive Carcinoma Harboring theNTRK3G623RSolvent-Front Mutation. JCO Precision Oncology. 5(5). 687–694. 4 indexed citations
8.
Uhrig, Sebastian, Julia Ellermann, Tatjana Walther, et al.. (2021). Accurate and efficient detection of gene fusions from RNA sequencing data. Genome Research. 31(3). 448–460. 208 indexed citations breakdown →
9.
Loosen, Sven H., Nadine T. Gaisa, Maximilian Schmeding, et al.. (2020). Prolonged Survival of a Patient with Advanced-Stage Combined Hepatocellular-Cholangiocarcinoma. Case Reports in Gastroenterology. 14(3). 658–667. 3 indexed citations
10.
Kreutzfeldt, Simon, Abbas Agaimy, Gunhild Mechtersheimer, et al.. (2020). Successful BRAF/MEK inhibition in a patient with BRAFV600E-mutated extrapancreatic acinar cell carcinoma. Molecular Case Studies. 6(4). a005553–a005553. 15 indexed citations
11.
Uhrig, Sebastian, Damian Stichel, Pascal St-Onge, et al.. (2020). An optimized workflow to improve reliability of detection of KIAA1549:BRAF fusions from RNA sequencing data. Acta Neuropathologica. 140(2). 237–239. 2 indexed citations
12.
Kreutzfeldt, Simon, Leonidas Apostolidis, Małgorzata Oleś, et al.. (2019). Clinical outcome of personalised treatment guided by genome and transcriptome sequencing in patients with neuroendocrine neoplasms: Updated results from the German NCT/DKTK MASTER trial. Annals of Oncology. 30. vii6–vii6. 1 indexed citations
13.
Horak, Peter, Simon Kreutzfeldt, Andreas Möck, et al.. (2019). Comprehensive genomic and transcriptomic profiling in advanced-stage cancers and rare malignancies: Clinical results from the MASTER trial of the German Cancer Consortium. Annals of Oncology. 30. vii24–vii24. 2 indexed citations
14.
Apostolidis, Leonidas, Simon Kreutzfeldt, Małgorzata Oleś, et al.. (2018). Prospective genome and transcriptome sequencing in advanced-stage neuroendocrine neoplasms. Annals of Oncology. 29. viii468–viii468. 1 indexed citations
15.
Uhrig, Sebastian & Holger Klein. (2018). PingPongPro: a tool for the detection of piRNA-mediated transposon-silencing in small RNA-Seq data. Bioinformatics. 35(2). 335–336. 17 indexed citations
16.
Uhrig, Sebastian, Martina Fröhlich, Barbara Hutter, & Benedikt Brors. (2018). PO-400 Arriba – fast and accurate gene fusion detection from RNA-seq data. ESMO Open. 3. A179–A179. 11 indexed citations
17.
Czink, Elena, Matthias Kloor, Benjamin Goeppert, et al.. (2017). Successful immune checkpoint blockade in a patient with advanced stage microsatellite-unstable biliary tract cancer. Molecular Case Studies. 3(5). a001974–a001974. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026